Related Experiment Video
Updated: Aug 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month study
Bruce J Kinon1, Hong Liu-Seifert, Jonna Ahl
1Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Drop Code 4133, Indianapolis, IN 46285, USA. bj_kinon@lilly.com
Abstract:
Our objective was to compare lipid profiles of schizophrenic patients treated with conventional antipsychotics or risperidone to those of patients switched to olanzapine. Our results indicate that in patients switched to olanzapine, fasting serum lipids initially increased then returned to pretreatment levels, and endpoint lipid levels were not significantly different from those in patients remaining on conventional antipsychotics or risperidone.
Related Concept Videos
Longitudinal Studies
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Longitudinal Research
Bioavailability Study Design: Healthy Subjects Versus Patients
